0
In September 2025, the European Medicines Agency’s (EMA) Biosimilar Medicinal Products Working Party (BMWP) held a ‘Workshop on a tailored clinical approach in biosimilar development’ to discu...
More >- Home
-
Generics
News
- FDA approves generic teriparatide and levetiracetam
- US generics launch and approval for Dr Reddy’s and Lupin
- Five Chinese companies join UN’s MPP for Covid-19 medicines
- South Korean companies to make generic Bridion and COVID-19 drugs
Research
- Japan’s drug shortage crisis: challenges and policy solutions
- Saudi FDA drug approvals and GMP inspections: trend analysis
- Generic medications in the Lebanese community: understanding and public perception
- Community pharmacists’ understanding of generic and biosimilar drugs: Lebanon case study
-
Biosimilars
News
- Biosimilars referencing Amgen’s Neulasta and Neupogen launch in Canada and US
- EMA recommends approval for nine biosimilars
- FDA approves six denosumab biosimilars
- EMA recommends approval for four biosimilars targeting three therapies
- MORE EDITORIAL SECTIONS
- Search
